Series B - Checkmate Pharmaceuticals
Investment Firm
Overview
Checkmate Pharma is a clinical stage biopharmaceutical company developing a new approach for cancer immunotherapy.
Announced Date
Jun 15, 2017
Funding Type
Series B
Highlights
Location
United States, North America
Social
Participant Investors
4
Round Details and Background
Checkmate Pharmaceuticals raised $27000000 on 2017-06-15 in Series B
Checkmate Pharma is a clinical stage biopharmaceutical company developing a new approach for cancer immunotherapy.
Company Funding History
5
| Announcment Date | Transaction Name | Number Of Investors | Lead Investor | Money Raised |
|---|---|---|---|---|
| Jan 27, 2020 |  Venture Round - Checkmate Pharmaceuticals | - | 16.0M | |
| Jun 10, 2020 | Series C - Checkmate Pharmaceuticals | 11 | - | 85.0M |
| Jun 15, 2017 | Series B - Checkmate Pharmaceuticals | 5 | - | 27.0M |
| Aug 12, 2015 | Series A - Checkmate Pharmaceuticals | 2 | - | 20.0M |
Recent Activity
There is no recent news or activity for this profile.